Home
Conditions
Lymphoma, Non-Hodgkin

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

2,772 public trials 697 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Active, Not Recruiting

Circulating Tumor DNA Sequencing in Patients With Peripheral T-cell Lymphomas

NCT06089941

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Centre Henri Becquerel Rouen, France

View Trial Details

Active, Not Recruiting

Study of Valemetostat Tosylate as a Single Agent in Patients With Relapse/Refractory B-cell Lymphoma

NCT04842877

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: A.Z. Sint Jan AV Bruges, Belgium

University Hospital Gent Ghent, Belgium

CH Tourelle Peltzer Verviers, Belgium

CHU Mont-Godinne Yvoir, Belgium

View all 22 locations

View Trial Details

Active, Not Recruiting

Venetoclax and Acalabrutinib in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma

NCT03946878

Conditions: Blastoid Variant Mantle Cell Lymphoma, CCND1 Protein Overexpression, CD20 Positive, +16 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

A Study of Tazemetostat With Rituximab and Abbreviated Bendamustine in the Frontline Treatment of High Tumor Burden Follicular Lymphoma

NCT05551936

Conditions: Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Northwestern University Chicago, Illinois, United States

University of Illinois Cancer Center Chicago, Illinois, United States

Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States

Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Active, Not Recruiting

BAFFR Targeting CAR-T Cells for the Treatment of Relapsed or Refractory B-cell ALL

NCT04690595

Conditions: Burkitt Lymphoma, DNA Virus Infections, Disease Attributes, +19 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Active, Not Recruiting

CD19 Chimeric Receptor Expressing T Lymphocytes In B-Cell Non Hodgkin's Lymphoma, ALL & CLL

NCT00586391

Conditions: Acute Lymphocytic Leukemia, B Cell Lymphoma, Chronic Disease, +20 more
Locations: Houston Methodist Hospital Houston, Texas, United States

Texas Children's Hospital Houston, Texas, United States

View Trial Details

Active, Not Recruiting

A Phase IIa Clinical Study of Purinostat Mesylate for Injection in Patients With Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma

NCT06485219

Conditions: Cutaneous T-cell Lymphoma (CTCL), Disease Attributes, Hemic and Lymphatic Diseases, +15 more
Locations: Ruijin Hospital, Shanghai Jiaotong University School Of Medicine Shanghai, Shanghai Municipality, China

West China Hospital Sichuan University Chengdu, Sichuan, China

View Trial Details

Active, Not Recruiting

Nivolumab With DA-REPOCH Chemotherapy Regimen in Treating Patients With Aggressive B-Cell Non-Hodgkin's Lymphoma

NCT03749018

Conditions: Aggressive Non-Hodgkin Lymphoma, Ann Arbor Stage I Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma, Ann Arbor Stage II B-Cell Non-Hodgkin Lymphoma, +22 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Active, Not Recruiting

A Trial to Learn if Odronextamab Combined With Chemotherapy is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Chemotherapy for Adult Participants With Follicular Lymphoma

NCT06097364

Conditions: Disease Attributes, Follicular Lymphoma (FL), Hemic and Lymphatic Diseases, +12 more
Locations: Boca Raton Clinical Research (BRCR) Global Plantation, Florida, United States

Investigative Clinical Research of Indiana Noblesville, Indiana, United States

Cancer Center of Kansas Wichita, Kansas, United States

University of Kentucky Lexington, Kentucky, United States

View all 145 locations

View Trial Details

Active, Not Recruiting

Italian Real-World Study of Epcoritamab in Relapsed or Refractory DLBCL

NCT07393204

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
Locations: IRCCS Ospedale San Raffaele Milan, Italy

View Trial Details

Lymphoma, Non-Hodgkin

Lymphoma, Non-Hodgkin trial results

Related conditions